Mass cytometry profiling of human dendritic cells in blood and tissues

Marcela Alcántara-Hernández1, Juliana Idoyaga2

  • 1Microbiology & Immunology Department and Immunology Program, Stanford University School of Medicine, Stanford, CA, USA.

Nature Protocols
|September 4, 2021
PubMed

Insights

This study presents an optimized mass cytometry protocol for analyzing rare human dendritic cells (DCs) in blood and tissues. The method enhances the characterization of these crucial immune cells, even in low numbers.

Area of Science:

  • Immunology
  • Cell Biology
  • Biotechnology

Background:

  • Mass cytometry enables in-depth protein profiling of immune cells.
  • Analyzing minor immune cell populations, like dendritic cells (DCs), is challenging due to low cell numbers and mass cytometry's throughput limitations.
  • Dendritic cells are critical for initiating and modulating immune responses.

Purpose of the Study:

  • To provide an optimized, step-by-step protocol for characterizing human dendritic cell populations in blood and tissues using mass cytometry.
  • To enable the analysis of both known and emerging dendritic cell subsets.
  • To facilitate the study of dendritic cells in various biological contexts, including health, disease, and vaccination.

Main Methods:

  • Development of a detailed protocol for single-cell suspension generation, sample enrichment, staining, acquisition, and data analysis.
  • Incorporation of a barcoding strategy to reduce acquisition variability and enable analysis of low cell numbers (~20,000).
  • Emphasis on negative selection techniques for immune cell enrichment to prevent activation of minor populations.

Main Results:

  • The protocol is optimized for the characterization of human dendritic cells using mass cytometry.
  • The barcoding option allows for reliable analysis of limited dendritic cell numbers.
  • Negative selection effectively enriches for minor immune cell populations without activation.

Conclusions:

  • This robust and reliable protocol facilitates the comprehensive analysis of human dendritic cells.
  • The optimized method supports the study of dendritic cells in diverse conditions, including health, disease, and vaccination.
  • The protocol addresses the challenge of analyzing low-abundance dendritic cell populations, advancing immunological research.

Related Concept Videos